Search Contract Opportunities

Engagement with Compounding Outsourcing Facilities   3

ID: FDA-RFP-1223623 • Type: Synopsis Solicitation
Opportunity Assistant

Hello! Please let me know your questions about this opportunity. I will answer based on the available opportunity documents.

Please sign-in to link federal registration and award history to assistant. Sign in to upload a capability statement or catalogue for your company

Some suggestions:
Please summarize the work to be completed under this opportunity
Do the documents mention an incumbent contractor?
I'd like to anonymously submit a question to the procurement officer(s)

Description

Posted: Aug. 6, 2020, 3:27 p.m. EDT

AMENDMENT 1 to FDA-RFP-1223623 (Support for the Establishment and Operation of a Center of Excellence for Engagement with Compounding Outsourcing Facilities)

The purpose of Amendment 1 to FDA-RFP-1223623 is to post FDA responses to timely vendor questions received for this solicitation. Amendment 1 includes an "FDA Responses to Vendor Questions" document, an Amendment 1 revision to the solicitation document and an Amendment 1 revision to the Statement of Work. All revised documents are attached and changes are highlighted in yellow throughout the documents. Please refer to the solicitation Amendment 1 documents for further information.

Posted: July 21, 2020, 12:32 p.m. EDT
Show All

Overview

Agency
Food and Drug Administration (FDA) [HHS]
Response Deadline
Aug. 21, 2020, 2:00 p.m. EDT Past Due
Posted
July 21, 2020, 12:32 p.m. EDT (updated: Aug. 6, 2020, 3:27 p.m. EDT)
Set Aside
None
NAICS
541990 - All Other Professional, Scientific, and Technical Services
PSC
R408 - Support- Professional: Program Management/Support
Place of Performance
Silver Spring, MD 20993 United States
Source
SAM
Current SBA Size Standard
$19.5 Million
Pricing
Multiple Types Common
Est. Level of Competition
Average
On 7/21/20 Food and Drug Administration issued Synopsis Solicitation FDA-RFP-1223623 for Engagement with Compounding Outsourcing Facilities due 8/21/20. The opportunity was issued full & open with NAICS 541990 and PSC R408.
Primary Contact
Name
Benjamin Golway   Profile
Email
benjamin.golway@fda.hhs.gov
Phone
(301) 837-7464

Documents

Posted documents for Synopsis Solicitation FDA-RFP-1223623

Question & Answer

The AI Q&A Assistant has moved to the bottom right of the page

Opportunity Lifecycle

Procurement notices related to Synopsis Solicitation FDA-RFP-1223623

Award Notifications

Agency published notification of awards for Synopsis Solicitation FDA-RFP-1223623

Contract Awards

Prime contracts awarded through Synopsis Solicitation FDA-RFP-1223623

Incumbent or Similar Awards

Potential Bidders and Partners

Awardees that have won contracts similar to Synopsis Solicitation FDA-RFP-1223623

Similar Active Opportunities

Open contract opportunities similar to Synopsis Solicitation FDA-RFP-1223623

Additional Details

Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA OFFICE OF ACQ GRANT SVCS
FPDS Organization Code
7524-00223
Source Organization Code
100188033
Last Updated
Sept. 5, 2020
Last Updated By
PI33_DR_IAE_51681
Archive Date
Sept. 5, 2020